Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Human FFAR1 Antibodies:
anti-Mouse (Murine) FFAR1 Antibodies:
anti-Rat (Rattus) FFAR1 Antibodies:
Go to our pre-filtered search.
Cow (Bovine) Polyclonal FFAR1 Primary Antibody for WB - ABIN2792205
Sum, Tikhonova, Neumann, Engel, Raaka, Costanzi, Gershengorn: Identification of residues important for agonist recognition and activation in GPR40. in The Journal of biological chemistry 2007
Human Polyclonal FFAR1 Primary Antibody for ELISA, WB - ABIN250421
Hardy, St-Onge, Joly, Langelier, Prentki: Oleate promotes the proliferation of breast cancer cells via the G protein-coupled receptor GPR40. in The Journal of biological chemistry 2005
Comparison with an additional 2.2-A structure of the human GPR40-MK-8666 binary complex reveals an induced-fit conformational coupling between the partial agonist and AgoPAM binding sites, involving rearrangements of the transmembrane helices 4 and 5 (TM4 (show TPM4 Antibodies) and TM5) and transition of the intracellular loop 2 (ICL2) into a short helix.
Results show that GPR40 negatively regulated the cell motile and invasive activities of HT1080 (show CDC123 Antibodies) cells suggesting that GPR40 negatively regulates the tumor progression of fibrosarcoma cells.
Brain free long-chain fatty acids-GPR40/FFA1 signaling might have an important role in the modulation of endogenous pain control systems. (review)
It regulates insulin (show INS Antibodies) secretion in pancreatic beta-cells. (review)
Data from molecular docking simulations suggest that the binding pocket of GPR40 exhibits binding of free fatty acids (FFA) with chain lengths of C15 or fewer; for FFA with lengths longer than C15, part of alkyl chain extends out of binding pocket.
GPR120 (show O3FAR1 Antibodies) negatively and GPR40 positively regulate cellular functions during tumor progression in lung cancer cells.
Increased membrane permeability induced by linoleic acid is mediated by an intracellular signaling pathway activated by GPR40 that leads to an increase in membrane levels of Cx43 (show GJA1 Antibodies) phosphorylated at serine 373 via Akt (show AKT1 Antibodies).
These data demonstrate that R104 in GPR40 is critically involved in the normal receptor functions. Interestingly, R104P is a registered single-nucleotide polymorphism of GPR40.
Characterizing pharmacological ligands to study the long-chain fatty acid receptors GPR40/FFA1 and GPR120 (show O3FAR1 Antibodies)/FFA4
results suggest that FFAR1 is the functionally dominant free fatty acid receptor in both human and guinea pig airway smooth muscle.
These findings suggested that dysfunction of the GPR40/FFAR1 signaling pathway altered the endogenous pain control system and that this dysfunction might be associated with the development of chronic pain.
Together, our data indicate effects of AgoPAMs that go beyond glucose lowering previously observed with GPR40 partial agonist treatment with additional potential for weight loss.
These results support the hypothesis that mercaptoacetate stimulates food intake by blocking fatty acid effects on GPR40.
These results indicated that GPR120 (show O3FAR1 Antibodies) enhanced and GPR40 inhibited the cell motile activity of highly migratory osteosarcoma cells.
Results suggest that brain GPR40/FFAR1 is associated with anxiety- and depression-related behavior regulated by the increment of noradrenaline in the brain.
Data revealed a weak influence of GPR40 agonist on osteoblast markers expression. Nevertheless, a significant increase in OPG (show TNFSF11 Antibodies) expression was observed upon GW9508 treatment that contribute to explain the GPR40-related osteoporosis prevention
In the retinas of Vldlr (show VLDLR Antibodies)(-/-) mice with low fatty acid uptake but high circulating lipid levels, we found that Ffar1 suppresses expression of the glucose transporter Glut1 (show SLC2A1 Antibodies)
activation of the hypothalamic GPR40/FFA1 signaling pathway may regulate beta-endorphin (show POMC Antibodies) release via PC2 (show CBX4 Antibodies), and regulate the endogenous pain control system
These results suggest that both PPARgamma (show PPARG Antibodies) and GRP40 are required for RSG-induced inhibition of mouse calvaria osteoblast differentiation, which is mediated through GSK3beta (show GSK3b Antibodies)-dependent pathway.
GPR40 signaling pathway plays an important suppressive role in spinal nociceptive processing after inflammation or nerve injury
This gene encodes a member of the GP40 family of G protein-coupled receptors that are clustered together on chromosome 19. The encoded protein is a receptor for medium and long chain free fatty acids and may be involved in the metabolic regulation of insulin secretion. Polymorphisms in this gene may be associated with type 2 diabetes.
free fatty acid receptor 1
, G protein-coupled receptor 40
, G-protein coupled receptor 40
, G protein-coupled receptor GPR40